Open AccessLong-term efficacy and adverse reactions of IMRT combined with Endostar versus IMRT combined with chemotherapy for locally advanced nasopharyngeal carcinoma: a retrospective study
Author(s) -
Wei Chen,
Fangfang Wang,
Zhendong Yang,
Tingting Zhang,
Mingjun Shen,
Rensheng Wang,
Min Kyu Kang
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-3018
Subject(s) - medicine , nasopharyngeal carcinoma , cisplatin , chemotherapy , adverse effect , radiation therapy , incidence (geometry) , retrospective cohort study , oncology , nuclear medicine , optics , physics
This study aimed to analyze the long-term efficacy and late adverse reactions of intensity-modulated radiation therapy (IMRT) combined with recombinant human endostatin (Endostar) versus IMRT combined with concurrent chemotherapy (CCT) in patients with locoregionally advanced nasopharyngeal carcinoma (NPC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom